MBio Diagnostics, Inc. Will Present at Biotech Showcase in San Francisco, Monday January 7, 2013

(firmenpresse) - BOULDER, CO -- (Marketwire) -- 01/03/13 -- MBio Diagnostics, Inc., a diagnostics company focused on enabling better healthcare decisions through immediate multi-disease diagnostics, today announced that Michael J. Lochhead, Ph.D., Vice President of MBio Diagnostics, will present a company overview at the Biotech Showcase, on Monday, January 7 at 2:30 p.m. PST at the Parc 55 Hotel in San Francisco, CA. The presentation will focus on MBio's near-term plans to commercialize the first in a pipeline of diagnostic products on a single platform developed to deliver comprehensive testing of multiple diseases from a single sample.



MBio Diagnostics, Inc. () is a privately held clinical diagnostics and life sciences technology company based in Boulder, CO. MBio is developing a suite of simple, multiplexed diagnostic tests using its proprietary LightDeck™ technology. Initial product development focuses on high impact infectious diseases, including HIV, hepatitis, and influenza. The company's product development is aimed at decentralized testing, from the clinic to the home.



For more information visit MBio at or contact:

Michael Seely
MBio Diagnostics, Inc.
Phone: 303-952-2830
Fax: 303-951-1529
E-mail:

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 03.01.2013 - 22:00 Uhr
Sprache: Deutsch
News-ID 216587
Anzahl Zeichen: 0

contact information:
Town:

BOULDER, CO

Kategorie:

Venture Capital

Diese Pressemitteilung wurde bisher 199 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"MBio Diagnostics, Inc. Will Present at Biotech Showcase in San Francisco, Monday January 7, 2013"
steht unter der journalistisch-redaktionellen Verantwortung von

MBio Diagnostics, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

MBio Diagnostics, Inc. Closes $6.3 Million in Series B Funding ...

BOULDER, CO -- (Marketwired) -- 05/21/15 -- MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced today the closing of $6.3 million in Series B financing led by new and existing ...

MBio Diagnostics, Inc. Rapid Detection Platform Validated in Independent Study ...

BOULDER, CO -- (Marketwired) -- 03/16/15 -- MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced today the publication of a study demonstrating the speed, utility and multiplexi ...

MBio Diagnostics, Inc. Awarded Contract for Diagnostic Development With the U.S. ...

BOULDER, CO -- (Marketwired) -- 11/04/14 -- MBio Diagnostics, Inc. announced today it was awarded a three-year development contract with the U.S. Army's Walter Reed Army Institute of Research (WRAIR) for the "Development of a Ruggedized Po ...

Alle Meldungen von MBio Diagnostics, Inc.